Background and Purpose. Thepulpose of this study was to examine the validity qf the Peabody Developmental Gross Motor Scale (PDMSGM) as a n evaluative measure of infants receiving physical therapy. Subjects and Methods. Infants who attended a n early interuention program (N= 124) were Selection of a developmental assessment should be dependent on the ability of the physical therapist to identih the purpose of assessment and to critically review published information for evidence of a test's validity specific to the intended use. Standardized developmental assessments are administered for several different purposes, including screening, diagnosis, determination of eligi-
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bility for public-funded early intervention programs, treatment planning, and measurement of change for evaluating the effectiveness of intervention.
grouped by diagnosis: cerebral palsy, Down syndrome, hydrocephalus, preterm

Sandra L Jones with developmental delay, full term with developmental delay, and other. 7he PDMS-GM was administered to each infant three times over a 6-month period by n thelapist who did not provide treatment. Results. Mean scaled scores and age-equivalent scores increased for each group. Individual change was examined using the reliable change index, 7he results indicated that the change in total raw score for 62% of the infants was greater than what could be attributed to measurement error. When minimal clinically important change was dejned as 10 scaled scorepoints, the index of responsiveness was equal to 0.5. 7hisjnding indicates that a sample sire of 68 subjects per group would be needed when the PDMS-GM is used as a n outcome measure in research. Conclusion and Discussion. 7he mean change scores for each group support the use of the PDMS-GM as a n evaluative measure. For many infants, particularly infants with cerebral palsy, the PDMS-GM was not responsive to change over a 6-month period. 7he index of responsiveness suggests that the PDMS-GM should be used only as a n outcome measure in large clinical trials. The PDMS-GM is not recornmended for evaluating the direct effects of physical therapy but is recommended for providing a global measure of change in motor development
as part qf a multidimensional assessment. [Palisano RJ, Kolobe Discriminative measures are intended to distinguish between individuals with or without a particular characteristic or f~1nction.l For example, normreferenced assessments are based on the average performance of children without impairments or disabilities and are thus designed to discriminate between infants with and without developn~ental delays. The use of a discriminative measure is appropriate when the purpose of testing is to screen, diagnose, or determine eligibility for early intervention services. Alternatively, evaluative measures are used to measure the magnitude of change in development over time or after inter-vention.1 Criterion-referenced assessments that are based on task analysis, sequential stages, or mastery of a content domain without regard to performance of other children of the same age are preferable when the purpose of assessment is treatment planning or evaluation of the effects of treatment.2
Although norm-referenced assessments of motor development are intended to discriminate between children with and without motor delay, they have frequently been used as evaluative measures in research that has examined the effectiveness of physical therapy for infants with cerebral palsy and those at risk for neuromotor disabilities.Gi This practice is controversial. Rosenkium and col1eaguesQtated that norm-referenced motor assessments should not be used as evaluative measures until they are validated as responsive to changes made by children with motor dysfunction.
Responsiveness (ie, the ability to measure clinically important changes over time) is a type of validity that is necessary for an evaluative measure.' Rosenbaum et a16 and Boyce et alB have described several psychometric properties that are unique to a measure that is intended to evaluate motor function outcomes of intervention for children with cerebral palsy. Items must reflect the goals of intervention and the changes that children with cerebral palsy are capable of making. There should be a sufficient number of items above a child's present level of ability and a rating scale that includes several response options for partial as well as complete accomplishment of each item. The method of scoring should be quantitative and allow detection of small changes in performance.
The Peabody Developmental Gross Motor Scale (PDMS-GM)" is standardized and normed for ages from birth through 83 months and is intended for use by professionals from several disciplines, including physical thenpists. Folio and Fewell constn~cted the PDMS-GM to accomplish several purposes, including ( l) identfication of children with delayed motor development, (2) identification of a child's unique strengths and needs, (3) assessment of motor development over time or in response to intervention, and (4) identification of motor oblec-
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tives and intervention strategies when used with accompanying activity cards. The PDMS-GM, therefore, was designed for use as both a discriminative and an evaluative measure. Although Folio and Fewe119 state that a purpose of the PDMS-GM is to measure change across time or after intervention for children with motor impairments or delays and the PDMS-GM has been used in physical therapy outcome resear~11.~3,~~ the responsiveness of the PDMS-GM has not been investigated. The purpose of our study was to examine the validity of the PDMS-GbI as an evaluative measure of infants receiving physical therapy. We were interested in examining change fro111 three perspectives: mean change, individual change, and minimal clinically important change. The following research questions were examined: (1) Do infants grouped by diagnosis demonstrate an increase in PDMS-GM scaled scores and age-equivalent scores when tested three times over a (,-month period? (2) What percentage of infants demonstrate an increase in PDMS-GNI raw score that exceeds the change that could be explained by measurement error? and (3) What is the sample size requirernent when the PDMS-GM is used as an evaluative measure in treatment outcome research? The third question m:as addressed in two phases, which involved estimation of minimal clinically important change and determination of the index of respon~iveness.~
Method
Subjects
The subjects were 124 infants who met the following eligibility criteria: ( 1) were enrolled in an early intervention prograrn in which they received physical therapy, (2) had a motor delay as measured ly a z score of -1.5 or below on the PDMS-GM, (3) did not have a medical condition that prevented participation in physical therapy, and (4) had no progressive neurological disorder or medical condition in which progress in motor development would not be expected over a 6-month period. S~xty-one infants attended one of nine early interven- SD=6.9) at the start of the study. The ages of the 54 infants born preterrn were adjusted to account for gestational age at birth. One hundred infants were Caucasian, and 19 infants were African-American. The race of 5 infants was not reported.
Subjects were grouped by diagnosis based on review of intake forms and medical reports contained in each infant's early interention program file (Tab. 1). Thirty-six infants had cerebral palsy, 19 infants had Down syndrome, and 9 infants had hydrocephalus. Twenty-one preterrn infants and 20 full-term infants had a developmental delay in two or more don~lins, with no specific diagnosis. The criterion for developmental delay varied arnong the early intervention programs. but developmental delay was generally defined as an age-equivalent score that was a rninimum of 25% below the infant's chronological or adjusted age. The remaining 19 infants constituted a heterogeneous group that had the following diagnoses: spina bifida (n=5), genetic syndrome other than Don7n syndrome (n=4), microcephaly (n=4), congenital infection (11=2), congenital central nervous system malformation (n= 1). macrocephaly (n=l), autism (n=l), and head traurna ( n = l ) . 
Procedure
The PDMS-GM was administered to the infants at the start of the study and at 3-month and 6-month intervals following the standardized procedures outlined in the test manual. All of the testing was performed by therapists who did not provide treatment to any of the infants. A physical therapist or an occupational therapist administered all of the assessments. Sixty-six percent of the assessments were performed at the center at which the infants received services, and 34% of the assessments were performed in the infants' homes.
The occupational therapist and the physical therapist who administered the PDMS-GM to the infants who attended the early intervention programs in Massachusetts established interrater reliability by independently scoring the performance of nine subjects prior to data collection. The intraclass correlation coefficient (ICC[2,1]) for age-equivalent scores was .98.
The first author (RJP) established interrrrter reliability with the author (THK) who administered the PDMS-GM to the infants in Illinois and the author (SLJ) who administered the PDMS-GM to the infants in New Jersey. Prior to testing the infants who lived in Illinois, six infants were independently scored (three from videotape and three from direct observation) and the ICC (2,l)
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for age-equivalent scores was .95. To determine test-retest reliability, the author who administered the PDMS-GM to the infants in Illinois tested six infants twice within 1 week. The ICC (3,l) for age-equivalent scores was .99.
A similar procedure was followed prior to testing the infants who lived in New Jersey. Six infants were independently scored, three from videotape. The ICC (2,l) for raw scores of items administered was .96. One week later, the therapist readministered the PDMS-GM to three of the infants to determine test-retest reliability. The ICC (3,l) for raw scores of items administered was .98.
Data Analysis
The PDMS-GM raw scores were converted into scaled scores and ageequivalent scores using the tables contained in the test manual. Statistical analyses were performed using SPSS/ PC+, version 3.0.'
The distributions of scaled scores and age-equivalent scores for each group at each of the three test sessions were examined for skewness and kurtosis using the r distribution and an alpha level of ,001 I-The distributions of age-equivalent scores did not demonstrate skewness or kurtosis for any group. The distributions of scaled scores demonstrated skewness, kurtosis, or both, for three groups. For the preterm infants with developmental delays, the distribution of scaled scores for the 6-month test session demonstrated positive kurtosis and negative skewness. For the full-term infants with developmental delays and the infants with hydrocephalus, the distribution of scaled scores demonstrated positive kurtosis for two of the test sessions. Overall, the assumption of a normal distribution was not violated, and the data were analyzed using parametric statistics.
For where the S,,,, is the standard error of the diference between pretest and posttest scores that would be expected if no actual change had occurred.
The Sd,, for a particular test is computed from the standard error of measurement for a 95% confidence interval. The s,,, for the PDMS-GM was calculated using the formula:
where SE, is the standard error of measurement of the raw score for the age level of the PDMS-GM that corresponded to the infant's age at the initial assessment and SE, is the standard error of measurement for the raw score for the age level that corresponded to the infant's age at the 6-month assessment. Jacobson et allx proposed that an RCI larger than t 1.96 would be unlikely to occur without actual change (Pc.05).
The index of responsiveness7 was calculated to determine sample size requirements when the PDMS-GM is used as an outcome measure in clini-
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cal research. The equation for the index of responsiveness is
The numerator Delta (A) is the minimal clinic;3lly ilnportant change. The denominator is derived from the mean square error (MSE) of a univariate repeated-measures ANOVA and reflects within-subject variability. Delta has not been determined for the PDMS-GM scaled score. In this study, Delta was estimated as 10 points. This estimate i:; roughly equivalent to a I-month gain in age-equivalent score for the age levels of the infants in this study. The rationale for the estilnate was also based on pilot work that involved having two physical therapists independently view videotaped excerpts of consecutive test sessions for five infants who nude valying amounts of change during this study. The two infants judged as having nude minimal clinically important change by both therapists had a 1-month gain in age-equivalent score. The results of the one-way ANOVAs for repeated measures are summarized in between the 3-and 6-month test sessions.
Results
Mean
A graph of the RCI value for each infant's initial and 6-month raw scores rank ordered by group is presented in Figure 3 . 
Reliable change index (RCI) uu111es qf individual infants 1-ank oi*dered buy dtagnosis
Physical Therapy / Volume 7 5 , Number 11 / November 1995 infants with Down syndrome, 63% for infants with other diagnoses, 60% for full-term infants with developmental delays, 56% for infants with hydrocephalus, and 50% for infants with cerebral palsy.
The equation for the index of responsiveness (R) was solved when the numerator Delta (minimal clin~cally important change) was equal to 10 scaled score points (equivalent to a 1-month gain in age-equivalent score).
The MSE for the repeated-measures ANOVA for initial and 6-month scaled scores for the entire sample was 182.01. Entering this value into the responsiveness equation resulted in a denominator of 19.1 and an R of 0.5. Using a table of sample size requirements for various responsiveness levels. a sample size of 68 subjects per group would be required when R=0.5.7 This sample size requirement is based on an alpha of .05
(one tailed), a beta of .lo, and the assumption that the samples are mdependent.7
Discussion
The purpose of this study was to examine the validity of the PDMS-GM when used as an evaluative measure in infants receiving physical therapy from three perspectives: mean change, individual change. and minimal clinically important change. The changes in mean scores for each group provide initial support for the validity of the PDMS-GM when used as an evaluative measure for infants receiving physical therapy. Although the scaled score is recommended when the purpose of testing is to measure change in gross motor cievelopment, the infants in this study also made gains in ageequivalent scores. Although an increase in raw score of 1 or 2 points increased the scaled score, a gain of I>etween 5 and 12 points was necessary to increase the age-equivalent scores achieved by the infants in this study. The finding that the mean ageequivalent scores for each group increased between a mean of 1.0 and 2.1 months for the 3-month intervals and between a mean of 2.2 and 4.0 months for the 6-nlonth interval suggests that the changes were of clinical importance.
Each subject's change in PDMS-GM raw score was also examined because decisions in clinical practice are made on an individual basis. Furthermore, Jacobson et allx contend that statistical analyses based on group means provide no information on the proportion of subjects who benefited from the treatment. The RCI was developed as one criterion for determining improvement in individual clients based on the premise that for individual change to be considered statistically significant, it must also be statistically reliable.IX The RCI values for this study indicate that 62% of the infants denlonstrated an increase in raw score for the 6-month period that could not be attributed to either random variation or measurement error associated with the PDMS-GM. Although the majority of infants made true gains in raw scores, the changes made by 38% of the infants were not large enough to rule out measurement error. This finding suggests that for many infants, particularly those with neuromotor impairments such as cerebral palsy, the PDMS-GM is not responsive to change over a 6-month period. Therapists, therefore, should take into consideration the standard error of the difference between initial and follow-up assessment scores to determine whether the change in PDMS-GM raw score made by individual children exceeds what could potentially be attributed to measurement error.
The results suggest that the PDMS-GM has limitations when used as an evaluative measure in infants with cerebral palsy. The mean scaled scores and age-equivalent scores of infants with cerebral palsy increased over a 6-month period; however, the amount of change was less than the changes made by the other groups. Furthermore, only 50% of infants with cerebral palsy made changes in raw score that exceeded what could potentially be attributed to random variation or measurement associated with the PDMS-GM. The results are not surprising given the number and severity of motor impairments associated with cerebral palsy and the fact that the construct of the PDMS-GM is based on motor development of children without motor delays or impairments. The Gross Motor Function Measure (GMFM)21 was recently designed and validated to measure change in gross motor function in children with cerebral palsy. Kolobe2' compared the GMFM and the PDMS-GM and reported that although infants made comparable changes on both measures, the construct; large number of items in the lying and rolling, s~tting, and crawling and kneeling domains: a four-point rating scale, and separate items for the right and left sides suggest that the GMFM is the preferred measure for evaluating change in infants with cerebral palsy.
What constitutes minimal clinically important change for a 6-month period has not been determined for the PDMS-GM. Our estimate of minimal clinically inlportant change was based on the in~pression that a gain in scaled score of 10 points alould require the infant to demonstrate emerging ability or acquisition of several postures and movements that parents and health care professionals would perceive as important for motor function. When minimal clinically important change was defined as 10 scaled score points, the sample size requirement of 68 subjects per group exceeds the sample size of all but one intervention study that included a control or comparison group.i 2"-25 This finding suggests that for research purposes, the PDMS-GM is appropriate for use as an outconle measure only when there is a large sample size or when evidence exists that the intenrention will produce a moderate or large treatment effect.
Although minimal clinically important change was used in this study to determine sample size, the concept has broader in~plications that have not been addressed in physical therapy outcome research. Changes that are statistically significant are not necessarily of clinical importance, and vice versa. Jaeschke et aI2" define minimal clinically important difference as the smallest diference in score that patients perceive as beneficial and that would mandate a change in the patients' management. Based on this definition, the question of what constitutes minimal clinically important change must reflect the perceptions of families and children who receive physical therapy. Ultimately, resolution of this issue may depend on the costto-benefit ratio of providing children and their families the services associated with achievement of minimal clinically important change.
The results of this study cannot be generalized to children with motor impaments who are above the age of 3 years. Subjects were selected based on the assumption that infants with motor impairments would be more likely to demonstrate changes on the PDMS-GM compared with children above 3 years of age. This assumption is based on the expectation that there are a sufficient number of items on the PDMS-GM below the 12-to 14-month age level to measure changes in postures and movements in supine, prone, quadruped, and sitting positions made over a 3-to 6-month period in infants with mild to moderate motor impairments, including infants with limited potential for short-term changes in standing and walking. For children with motor impairments who are 3 years of age and older, many items below the 12-to 14-month age level no longer reflect the focus of physical therapy, and there is a ceiling effect above this age level for children who are unable to stand and walk independently.
Although the mean change scores and to a lesser extent the individual change scores support the use of the PDMS-GM as an evaluative measure, the gains measured may not be directly related to the goals of physical therapy. The PDMS-GM is based on the motor development sequence and the change needed to pass successive items for a posture or movement may exceed the potential of infants with motor impairments and disabilities, especially when change is measured over a short period of time. The PDMS-GM was not constructed to measure changes in quality of movement, amount of caregiver assistance, the need for assistive devices and orthoses, or changes in motor function within contexts that are important for daily routines. When these areas are the focus of physical therapy, alternative or additional evaluative measures are recommended. Previous research supports the use of individualized outcome measures such as goal attainment scaling to measure small, but clinically meaningful, changes that are directly related to the focus of physical therapy.1"27 We recommend using the PDMS-GM to provide a global measure of change in motor development but not as the primary method of evaluating change in infants receiving physical therapy, especially infants with cerebral palsy.
Conclusions
This study was an initial attempt to examine the validity of the PDMS-GM when used as an evaluative measure of infants receiving physical therapy. Infants grouped by diagnosis made gains in mean scaled scores and ageequivalent scores over a 6-month period, and the magnitude of the mean changes was judged as clinically important. These findings provide support for use of the PIIMS-GM as an evaluative measure. The measurement error associated with change scores of individual subjects was examined using the KCI. The gains in raw score made by 38% of the infants were not of sufficient magnitude to conclude that an actual change in motor development had occurred. This finding suggests that for many infants who receive physical therapy, the PDMS-GM is not responsive to changes made over a 6-month period.
In particular, the changes made by infants with cerebral palsy were less than the changes made by the other groups, and only 50% of infants with cerebral palsy made changes in raw score that exceeded what could potentially be attributed to random variation or measurement error associated with the PDMS-GM.
The concept of minimal clinically important change has important implications for treatment outcome research and warrants further investigation.
When minimal clinically important change for a 6-month period is defined as 10 scaled score points, the sample size requirement would be 68 subjects per group. This requirement suggests that the PDMS-GM should be used as an outcome measure only in large clinical trials or when evidence exists that the intervention will produce a moderate or large treatment effect. In accordance with the recommendations of Neisworth and BagnatqLH we advocate that the PDMS-GM should be used as a global measure of change in motor development as part of an assessment that includes multiple dependent measures and derives data from multiple sources and contexts.
